Astrocyte Pharmaceuticals Inc.
A Novel Approach to Neuroprotection
Astrocyte Pharmaceuticals is a new neuroscience drug development company with a novel small molecule drug for the treatment of stroke, traumatic brain injuries and concussions. The company has demonstrated significant neuroprotective efficacy in multiple mouse models, with acute treatment administered as late as 24 hours post injury. The company has over $2M in previous investment, NIH & DOD grants to advance their promising drug candidate.